Skip to content

Innovaccer vs SpectraMedix

Innovaccer logo

Innovaccer

The AI Cloud for Autonomous Healthcare

1606 employees · est. 2014 · San Francisco, United States

VS
SpectraMedix logo

SpectraMedix

Powering Value-Based Contract Success

158 employees · est. 2009 · East Windsor, United States

SpectraMedix is the older company (2014 vs 2009); Innovaccer is the larger of the two.

Side-by-Side Comparison

Innovaccer SpectraMedix
Founded
2014 2009 older
Headquarters
San Francisco, United States East Windsor, United States
Employees
1606 larger 158
Industry
AI, Analytics, Data Analytics Analytics, Health Care
Funding Stage
Post IPO Not tracked yet
Total Funding
$728.10M Not tracked yet
Funding Rounds
9 Not tracked yet
Services
AI-Powered Assistants, Healthcare Data Unification, Predictive Analytics, Real-time Decision Making, Patient Record Integration Not tracked yet
Target Customers
Healthcare Providers, Payers, Public Healthcare Sector, Life Sciences Organizations, Clinically Integrated Networks Not tracked yet
Taxonomy
AI Cloud For HealthcareHealthcare Intelligence PlatformData Activation PlatformAutonomous Healthcare OperationsClinical And Financial OutcomesHealthcare Data Integration +9 Healthcare AnalyticsClinical Data TransformationQuality ImprovementValue-Based CareHealthcare ITPopulation Health Management +9
Website
innovaccer.com spectramedix.com
Innovaccer logo

About Innovaccer

Innovaccer, founded in 2014, is at the forefront of AI-driven healthcare transformation with its slogan, "The AI Cloud for Autonomous Healthcare." The company serves as the backbone for autonomous healthcare operations, leveraging AI to enhance clinical and financial outcomes throughout health syste...

SpectraMedix logo

About SpectraMedix

SpectraMedix, founded in 2009, aims to empower healthcare organizations on their journey to value-based care, as reflected in their slogan "Powering Your Journey to Value Based Care." The company specializes in leveraging clinical data to drive quality improvement and achieve measurable clinical and...

Also comparing in this category

Comparing more than these two?

Get Innovaccer, SpectraMedix and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Innovaccer compare?

A PDF of Innovaccer and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Innovaccer was founded in 2014, based in San Francisco, United States, with 1,606 employees. Innovaccer, founded in 2014, is at the forefront of AI-driven healthcare transformation with its slogan, "The AI Cloud for Autonomous Healthcare." The company serves as the backbone for autonomous hea. SpectraMedix was founded in 2009, based in East Windsor, United States, with 158 employees. SpectraMedix, founded in 2009, aims to empower healthcare organizations on their journey to value-based care, as reflected in their slogan "Powering Your Journey to Value Based Care." The company spec.
Innovaccer has raised $728.10M and SpectraMedix no disclosed funding. Latest stage: Innovaccer Post IPO.
Both work in Analytics and Health Care and list healthcare analytics, value-based care and population health management among their focus areas.

Compare Innovaccer with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Innovaccer on 7 Apr 2026, and SpectraMedix on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout